leisure time -WSS

leisure time

author：fashion 2025-09-02 13:47:39 - browse：5

A protestor wears a transgender flag at a hearing on banning gender-affirming health care legislation in Missouri. AP Photo/Charlie Riedel

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans and restrictions from Republican lawmakers across the U.S.

The board of directors for the group, which represents 67,000 pediatricians, unanimously voted to reaffirm its 2018 position on the treatments. The board also voted to provide additional documents to support pediatricians, including clinical and technical reports, and to conduct an external review of research regarding the care.

“The additional recommendations also reflect the fact that the board is concerned about restrictions to accessing evidence-based health care for young people who need it,” Mark Del Monte, the academy’s CEO, said in a statement released by the group, calling the restrictions enacted by states “unprecedented government intrusion.”

“We therefore need to provide the best and most transparent process possible,” he said.

At least 21 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A federal judge struck down Arkansas’ ban as unconstitutional, and federal judges have temporarily blocked bans in Alabama and Indiana.

The judge who struck down Arkansas’ ban cited the position of the groups in his ruling against the ban. Arkansas has appealed the judge’s decision.

People opposed to such treatments for children argue they are too young to make such decisions about their futures.

Every major medical group, including the academy and the American Medical Association, has opposed the bans and has said the treatments are safe if administered properly.

The academy and the AMA support allowing children to seek the medical care, but they don’t offer age-specific guidance.

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Amylyx ALS drug failure raises questions and concerns

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Experts study whether long Covid risk adds up with each reinfection

The biotech scorecard for Q4: 16 stock

RSV shot was 90% effective at preventing hospitalizations in kids

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Setback for rare diseases as Taysha Gene Therapies pulls back

knowledge

leisure time

focus

Cancer drug shortages should be causing more outrage

Sen. Paul opposes bill to ban Chinese biotechs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Continuity nursing helped my family in our darkest PICU moments

Congress extends some pandemic preparedness programs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What will Novo Nordisk's VC do with its influx of cash?

What does generative AI mean for health care? We asked experts

The Karikó problem: Lessons for funding basic research

hotspot

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

The drug industry has found itself all alone in Washington

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

European officials brace for rough respiratory virus season

First medicine developed to treat MASH expected to be approved soon

Novo Nordisk obesity pill bests Wegovy in early trial

focus

focus

Wikipedia

entertainment